High-flow nasal oxygen therapy didn't improve survival with maintenance of functional independence after cardiac surgery in high-pulmonary-risk patients, the NOTACS trial showed. Whether patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results